Sickle Cell Disease Clinical Trials in Washington D.C., District of Columbia
13 recruitingWashington D.C., District of Columbia
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Sickle Cell Disease
Novartis Pharmaceuticals315 enrolled31 locationsNCT06439082
Recruiting
Phase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sickle Cell Disease
Novo Nordisk A/S408 enrolled172 locationsNCT06612268
Recruiting
Phase 2
Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
Sickle Cell DiseaseVaso-occlusive Pain Episode
Suvankar Majumdar99 enrolled1 locationNCT06635902
Recruiting
Phase 4
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Sickle Cell Disease
Novartis Pharmaceuticals130 enrolled30 locationsNCT04657822
Recruiting
Phase 2
A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)
Sickle Cell Disease
Agios Pharmaceuticals, Inc.56 enrolled32 locationsNCT06924970
Recruiting
Phase 3
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Sickle Cell DiseaseThalassemia
Novo Nordisk A/S480 enrolled103 locationsNCT06609226
Recruiting
Phase 2
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
Sickle Cell Disease
Robert Nickel100 enrolled7 locationsNCT03587272
Recruiting
Cooperative Assessment of Late Effects for SCD Curative Therapies
Sickle Cell DiseaseHeart DiseasePulmonary Disease+1 more
Vanderbilt University Medical Center750 enrolled5 locationsNCT05153967
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
ThrombophiliaThrombosisSickle Cell Disease+10 more
American Thrombosis and Hemostasis Network3,000 enrolled71 locationsNCT04398628
Recruiting
Phase 2
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
Sickle Cell Disease
Children's National Research Institute12 enrolled1 locationNCT06358638
Recruiting
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Sickle Cell Disease (SCD)
University of Rochester480 enrolled37 locationsNCT06941389
Recruiting
Not Applicable
Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
Sickle Cell Disease
Children's National Research Institute50 enrolled1 locationNCT06770010
Recruiting
Not Applicable
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
Sickle Cell Disease
Children's National Research Institute20 enrolled1 locationNCT05099874